Close
  Indian J Med Microbiol
 

Figure 4: Cumulative probabilities of prostate cancer detection according to free to total prostate-specific antigen (PSA) ratio during follow-up in participants with baseline PSA levels of 2.1-10.0 ng mlsup>−1 (modified from Reference[65]).

Figure 4: Cumulative probabilities of prostate cancer detection according to free to total prostate-specific antigen (PSA) ratio during follow-up in participants with baseline PSA levels of 2.1-10.0 ng mlsup>−1</sup> (modified from Reference<sup>[65]</sup>).